60 Degrees Pharmaceuticals effects 1:12 reverse stock split to regain Nasdaq compliance

60 DEGREES PHARMACEUTICALS, INC.

Reverse stock split at 1-for-12 ratio effective August 12, 2024; new CUSIP 83006G203.
Split aims to bring stock price above Nasdaq's $1.00 minimum bid requirement.
Stockholders approved reverse split range on July 16; Board set exact ratio on July 19.
No fractional shares issued; all fractional amounts rounded up to one whole share.
Common stock symbol SXTP unchanged; warrants symbol SXTPW unchanged.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.